VNCOP-B plus rituximab effective in diffuse large B-cell lymphoma in the elderly.

The article discusses research on the effectiveness of a combination therapy including cyclophosphamide, mitoxantrone, vincristine, etoposide, bleomycin and prednisone plus rituximab in treating elderly patients with diffuse large B-cell lymphoma. It references a study published in a 2007 issue of "Leukemia and Lymphoma." The study revealed the effectiveness of the therapy in inducing a good remission rate with moderate toxic effects in the elderly patients.